SGLT2 Inhibitors, Functional Capacity, and Quality of Life in Patients With Heart Failure: A Systematic Review and Meta-Analysis.

SGLT2 Inhibitors, Functional Capacity, and Quality of Life in Patients With Heart Failure: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Apr 01; 7(4):e245135.

View in: PubMed

subject areas

Aged
Heart Failure
Humans
Middle Aged
Quality of Life
Stroke Volume
Ventricular Function, Left

authors with profiles

Sean Pinney